Correlation of telomere length to malignancy potential in non‑melanoma skin cancers

Yamada‑Hishida,Hanae; Nobeyama,Yoshimasa; Nakagawa,Hidemi

doi:10.3892/ol.2017.7278

Correlation of telomere length to malignancy potential in non‑melanoma skin cancers

Authors:
- Hanae Yamada‑Hishida
- Yoshimasa Nobeyama
- Hidemi Nakagawa
View Affiliations

Affiliations: Department of Dermatology, The Jikei University School of Medicine, Tokyo 105‑8461, Japan
Published online on: October 26, 2017 https://doi.org/10.3892/ol.2017.7278
Pages: 393-399

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Telomeres are associated with cell fate and aging through their role in the cellular response to stress and growth stimulation resulting from previous cell divisions and DNA damage. Telomere shortening has been observed in most human cancers, and is known to be a feature of malignancy. The aim of this study is to clarify whether telomere length is related to the malignant potential of non‑melanoma skin cancers. Telomere length was analyzed using tissue quantitative fluorescence in situ hybridization in 36 non‑melanoma skin cancers including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), Bowen's disease (BD) and actinic keratosis (AK), and also in 26 samples of normal‑appearing epidermal tissue surrounding or located close to each tumor. The fluorescence intensities of telomeres and centromeres within nuclei were determined, and the telomere‑centromere ratio (TCR) was then calculated in each sample. The resulting histograms suggested that the TCR values for each type of tumor cell were distributed in a lower range than those for epidermal cells located close to the corresponding tumor type, and that the TCR values for SCC and BCC cells were distributed in a lower range than those for BD and AK cells. These results were completely consistent with the potential for metastasis and invasion of each tumor type, suggesting that telomere length in non‑melanoma skin cancer cells is intrinsically linked to their biological behavior.

View Figures

View References

1	Aubert G and Lansdorp PM: Telomeres and aging. Physiol Rev. 88:557–579. 2008. View Article : Google Scholar : PubMed/NCBI
2	Blackburn EH: Switching and signaling at the telomere. Cell. 106:661–673. 2001. View Article : Google Scholar : PubMed/NCBI
3	Harley CB, Futcher AB and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature. 345:458–460. 1990. View Article : Google Scholar : PubMed/NCBI
4	von Zglinicki T: Oxidative stress shortens telomeres. Trends Biochem Sci. 27:339–344. 2002. View Article : Google Scholar : PubMed/NCBI
5	Artandi SE and DePinho RA: Telomeres and telomerase in cancer. Carcinogenesis. 31:9–18. 2010. View Article : Google Scholar : PubMed/NCBI
6	Blasco MA: Telomeres and human disease: Ageing, cancer and beyond. Nat Rev Genet. 6:611–622. 2005. View Article : Google Scholar : PubMed/NCBI
7	Furugori E, Hirayama R, Nakamura KI, Kammori M, Esaki Y and Takubo K: Telomere shortening in gastric carcinoma with aging despite telomerase activation. J Cancer Res Clin Oncol. 126:481–485. 2000. View Article : Google Scholar : PubMed/NCBI
8	Kammori M, Takubo K, Nakamura K, Furugouri E, Endo H, Kanauchi H, Mimura Y and Kaminishi M: Telomerase activity and telomere length in benign and malignant human thyroid tissues. Cancer Lett. 159:175–181. 2000. View Article : Google Scholar : PubMed/NCBI
9	Broberg K, Björk J, Paulsson K, Höglund M and Albin M: Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 26:1263–1271. 2005. View Article : Google Scholar : PubMed/NCBI
10	Nakamura K, Furugori E, Esaki Y, Arai T, Sawabe M, Okayasu I, Fujiwara M, Kammori M, Mafune K, Kato M, et al: Correlation of telomere lengths in normal and cancers tissue in the large bowel. Cancer Lett. 158:179–184. 2000. View Article : Google Scholar : PubMed/NCBI
11	O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH, Crispin DA, et al: Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet. 32:280–284. 2002. View Article : Google Scholar : PubMed/NCBI
12	Firnhaber JM: Diagnosis and treatment of Basal cell and squamous cell carcinoma. Am Fam Physician. 86:161–168. 2012.PubMed/NCBI
13	Yanofsky VR, Mercer SE and Phelps RG: Histopathological variants of cutaneous squamous cell carcinoma: A review. J Skin Cancer. 2011:2108132011. View Article : Google Scholar : PubMed/NCBI
14	Röwert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, Kerl H, Sterry W and Stockfleth E: Actinic keratosis is an early in situ squamous cell carcinoma: A proposal for reclassification. Br J Dermatol. 3(156 Suppl): S8–S12. 2007. View Article : Google Scholar
15	Glogau RG: The risk of progression to invasive disease. J Am Acad Dermatol. 42:23–24. 2000. View Article : Google Scholar : PubMed/NCBI
16	Kim RH and Armstrong AW: Nonmelanoma skin cancer. Dermatol Clin. 30:125–139. 2012. View Article : Google Scholar : PubMed/NCBI
17	Wainwright LJ, Middleton PG and Rees JL: Changes in mean telomere length in basal cell carcinomas of the skin. Genes Chromosomes Cancer. 12:45–49. 1995. View Article : Google Scholar : PubMed/NCBI
18	Parris CN, Jezzard S, Silver A, MacKie R, McGregor JM and Newbold RF: Telomerase activity in melanoma and non-melanoma skin cancer. Br J Cancer. 79:47–53. 1999. View Article : Google Scholar : PubMed/NCBI
19	Han J, Qureshi AA, Prescott J, Guo Q, Ye L, Hunter DJ and De Vivo I: A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 129:415–421. 2009. View Article : Google Scholar : PubMed/NCBI
20	Leufke C, Leykauf J, Krunic D, Jauch A, Holtgreve-Grez H, Böhm-Steuer B, Bröcker EB, Mauch C, Utikal J, Hartschuh W, et al: The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas. Oncogene. 33:3506–3518. 2014. View Article : Google Scholar : PubMed/NCBI
21	Aida J, Izumiyama-Shimomura N, Nakamura K, Ishii A, Ishikawa N, Honma N, Kurabayashi R, Kammori M, Poon SS and Arai T: Telomere length variations in 6 mucosal cell types of gastric tissue observed using a novel quantitative fluorescence in situ hybridization method. Hum Pathol. 38:1192–1200. 2007. View Article : Google Scholar : PubMed/NCBI
22	Kammori M, Izumiyama N, Nakamura K, Kurabayashi R, Kashio M, Aida J, Poon SS and Kaminishi M: Telomere metabolism and diagnostic demonstration of telomere measurement in the human esophagus for distinguishing benign from malignant tissue by tissue quantitative fluorescence in situ hybridization. Oncology. 71:430–436. 2006. View Article : Google Scholar : PubMed/NCBI
23	Sugishita Y, Kammori M, Yamada O, Yamazaki K, Ito K, Fukumori T, Yoshikawa K and Yamada T: Biological differential diagnosis of follicular thyroid tumor and Hurthle cell tumor on the basis of telomere length and hTERT expression. Ann Surg Oncol. 21:2318–2325. 2014. View Article : Google Scholar : PubMed/NCBI
24	Kurabayashi R, Takubo K, Aida J, Honma N, Poon SS, Kammori M, Izumiyama-Shimomura N, Nakamura K, Tsuji E, Matsuura M, et al: Luminal and cancer cells in the breast show more rapid telomere shortening than myoepithelial cells and fibroblasts. Hum Pathol. 39:1647–1655. 2008. View Article : Google Scholar : PubMed/NCBI
25	Sugishita Y, Kammori M, Yamada O, Poon SS, Kobayashi M, Onoda N, Yamazaki K, Fukumori T, Yoshikawa K, Onose H, et al: Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening. Int J Oncol. 42:1589–1596. 2013. View Article : Google Scholar : PubMed/NCBI
26	Ikeda H, Aida J, Hatamochi A, Hamasaki Y, Izumiyama-Shimomura N, Nakamura K, Ishikawa N, Poon SS, Fujiwara M, Tomita K, et al: Quantitative fluorescence in situ hybridization measurement of telomere length in skin with/without sun exposure or actinic keratosis. Hum Pathol. 45:473–480. 2014. View Article : Google Scholar : PubMed/NCBI
27	Buckingham EM and Klingelhutz AJ: The role of telomeres in the ageing of human skin. Exp Dermatol. 20:297–302. 2011. View Article : Google Scholar : PubMed/NCBI
28	Aida J, Izumo T, Shimomura N, Nakamura K, Ishikawa N, Matsuura M, Poon SS, Fujiwara M, Sawabe M, Arai T and Takubo K: Telomere lengths in the oral epithelia with and without carcinoma. Eur J Cancer. 46:430–438. 2010. View Article : Google Scholar : PubMed/NCBI
29	Kuhn E, Meeker A, Wang TL, Sehdev AS, Kurman RJ and Ie M Shih: Shortened telomeres in serous tubal intraepithelial carcinoma: An early event in ovarian high-grade serous carcinogenesis. Am J Surg Pathol. 34:829–836. 2010. View Article : Google Scholar : PubMed/NCBI
30	Czarnecki D, Meehan CJ, Bruce F and Culjak G: The majority of cutaneous squamous cell carcinomas arise in actinic keratoses. J Cutan Med Surg. 6:207–209. 2002. View Article : Google Scholar : PubMed/NCBI
31	Fu W and Cockerell CJ: The actinic (solar) keratosis: A 21st-century perspective. Arch Dermatol. 139:66–70. 2003. View Article : Google Scholar : PubMed/NCBI
32	Cassarino DS, Derienzo DP and Barr RJ: Cutaneous squamous cell carcinoma: A comprehensive clinicopathologic classification-part two. J Cutan Pathol. 33:261–279. 2006. View Article : Google Scholar : PubMed/NCBI
33	Ra SH, Li X and Binder S: Molecular discrimination of cutaneous squamous cell carcinoma from actinic keratosis and normal skin. Mod Pathol. 24:963–973. 2011.PubMed/NCBI